ANI Pharmaceuticals reported $138.32M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
AbbVie USD 4.53B 345M Mar/2025
ANI Pharmaceuticals USD 138.32M 907K Jun/2025
Aurora Cannabis CAD 228.26M 25.75M Jun/2025
Canopy Growth CAD 93.82M 3.07M Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Hikma Pharmaceutical USD 986M 50M Dec/2024
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Novartis USD 6.31B 584M Jun/2025
Perrigo USD 1.22B 60.5M Jun/2025
Sun Pharmaceuticals INR 102.43B 3.08B Mar/2025
Teva Pharmaceutical Industries USD 3.5B 250M Jun/2025